Creative Biolabs Showcases Antibody Arrays for Protein Profiling, AKT Signaling and Autophagy Research
Oct 21, 2026
Complementary array formats support broad biomarker exploration and focused studies of signaling and cellular regulation.
Shirley, New York, United States, October 21, 2026 /MarketersMEDIA/ -- Creative Biolabs is highlighting three antibody array products that offer complementary approaches to protein research: a broad human biomarker proteomics array, an AKT pathway phosphorylation array, and a human autophagy array. The products provide options for researchers investigating protein abundance, signaling changes, and autophagy-related responses within a defined experimental setting.
Protein research often requires both a broad view of biological changes and a closer examination of specific molecular processes. A large screening panel can help identify candidate proteins for further study, while focused arrays can support investigation of selected pathways. Creative Biolabs' portfolio addresses these different research needs through glass slide and membrane formats.
Broad Profiling for Biomarker Exploration
The company's Human Biomarker Proteomics Antibody Array features 1,000 targets on a glass slide platform. Listed for quantitative detection of human proteins, the array accommodates sample types including cell culture supernatants, cell lysates, plasma, serum, tissue lysates, and other body fluids.
This broad coverage gives researchers an option for exploring protein profiles before selecting candidates for more focused analysis. Experimental design, sample preparation, and subsequent confirmation remain important when interpreting differences between study groups or treatment conditions.
Focused Analysis of AKT Pathway Phosphorylation
For researchers examining signaling responses, the AKT Pathway Phosphorylation Antibody Array provides a membrane-based panel of 18 targets. The product is listed for human and mouse reactivity and uses a semi-quantitative assay format.
Its panel includes phosphorylated forms of Akt, AMPKα, mTOR, PRAS40, and PTEN, among other signaling proteins. Measuring selected phosphorylation events can add information beyond protein abundance alone, helping researchers investigate how experimental conditions affect components of the AKT-related signaling network.
The array uses chemiluminescent imaging following sample incubation and antibody-based detection, offering a focused format for comparing selected signaling readouts across experimental conditions.
Connecting Signaling Studies with Autophagy Research
The Human Autophagy Antibody Array complements this pathway-focused approach with a membrane-based, semi-quantitative panel covering 20 autophagy-related targets in human samples.
AKT-related signaling and autophagy intersect through regulatory networks involving cellular growth, nutrient sensing, and stress responses. Examining these areas within the same research program may help investigators develop hypotheses about relationships between signaling changes and autophagy-related protein profiles. Measurements of protein levels, however, require complementary functional experiments to establish changes in autophagic flux.
The three products can therefore be considered at different stages of a research project, from broad protein exploration to targeted pathway analysis. They are separate research tools, and their use should be guided by the biological question, species compatibility, sample characteristics, and the information each assay measures.
Researchers can review individual product specifications and contact Creative Biolabs to discuss suitability for their experimental requirements. All three arrays are intended for research use only and are not intended for clinical use.
About Creative Biolabs
Creative Biolabs provides antibody products and research services supporting life science investigations. Its portfolio includes primary and secondary antibodies, antibody pairs, and antibody arrays for applications in protein detection, biomarker research, and cellular signaling studies.
Contact Info:
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs
Website: https://www.antibody-creativebiolabs.com/
Release ID: 89206812
If there are any deficiencies, problems, or concerns regarding the information presented in this press release that require attention or if you need assistance with a press release takedown, we encourage you to notify us without delay at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our diligent team is committed to promptly addressing your concerns within 8 hours and taking necessary actions to rectify any identified issues or facilitate the removal process. Providing accurate and trustworthy information is of utmost importance.
More News
Tech Stocks See Worst Day Since June, Pressuring Broader Market
The Nasdaq and the S&P 500 had their worst day since June as investors worried about spending on A.I. infrastructure.
US tech stocks see sharp falls as AI spending nears $1tn
Shares in Intel continue to fall while the tech-heavy Nasdaq opens at its lowest level in more than two months.
Lawsuit Accuses Education Dept. of Throttling Debt Cancellation Through PSLF Program
Public servants on the brink of student debt forgiveness are facing setbacks and extensive delays. The American Federation of Teachers sued to help them.
The Tech Tumult Rocks Wall Street
Investors are growing nervous about the huge spending bills that tech giants are amassing to pay for their bets on artificial intelligence.
Why Kalshi Wants to Repeal a 1958 Law About Onions
A law enacted after a brazen scheme to rig onion prices in the 1950s puts the vegetable, as well as box office receipts, off-limits for prediction markets.
Binance Hack Sends Crypto Stocks Tumbling
The rout hit publicly traded crypto exchanges and fintech companies, as well as cryptocurrencies like Bitcoin.
Meta Settles Social Media Addiction Case, Avoiding Trial
The case, brought by an 18-year-old Mississippi woman and set for trial next week, was the fourth of nine bellwether personal injury lawsuits.
City of London chief tops UK Black Powerlist
Ian Thomas, who heads the City of London Corporation, tops the Black Powerlist in its 21st year.
Binance's $6.3bn crypto hack biggest in history
Cryptocurrency giant Binance said on Thursday that $6.3bn (£4.7bn) of digital assets have been impacted by what is thought to be the biggest crypto hack on record.
New York Bought an Electric Ferry. The City Can’t Charge It.
Locations across the country want to launch electric ferries to cut carbon emissions, but there are challenges to the rollout.
Yorkshire Water boss resigns after firm downgraded
Nicola Shaw, who has led the company since 2022, will step down in January, it is announced.
Binance Suspends Withdrawals After Crypto Hackers Steal $6.3 Billion
The crypto exchange said it was compromised in what could be the biggest crypto heist ever. One research lab attributed the theft to “North Korea’s elite hacking unit.”
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.